Hyperion Defi (HYPD) risk factors

Item 1A of every Hyperion Defi, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open HYPD in Gloom →

Hyperion Defi's chart, financials and news, free in your browser.Open HYPD in Gloom →

FY2025 10-K risk factors
48 risks35 new47 dropped7 reworded
The company’s risk profile has shifted from biotech commercialization and financing to a concentrated HYPE-token treasury strategy.
Filed Mar 30, 2026
FY2024 10-K risk factors
60 risks
Hyperion Defi faces imminent going concern risks with only $2.1 million in cash as of December 31, 2024. The company carries $10.2 million in debt under a loan agreement with Avenue maturing November 1, 2025. It depends entirely on successfully commercializing its Mydcombi and clobetasol propionate products or completing a proposed business combination with Betaliq.
Filed Apr 15, 2025